Company performance
Current Price
as of Jan 16, 2025$10.20
P/E Ratio
N/A
Market Cap
$586.28M
Description
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Metrics
Overview
- HQBoston, MA
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerDNA
- Price$10.2+9.68%
Trading Information
- Market cap$586.28M
- Float66.98%
- Average Daily Volume (1m)1,427,103
- Average Daily Volume (3m)1,297,589
- EPS-$12.90
Company
- Revenue$217.95M
- Rev growth (1yr)60.65%
- Net income-$56.40M
- Gross margin67.24%
- EBITDA margin-38.71%
- EBITDA-$34.47M
- EV$252.33M
- EV/Revenue1.16
- P/EN/A
- P/S2.45
- P/B0.64
Documents
SEC Filings
Factset Street Account
Ginkgo Bioworks Holdings downgraded to neutral from buy at BTIG ($1.49, 0.00) (2023-11-09T11:45:14Z)
Earnings Calls
Wikipedia